LongRiver Investments
VC Fund
Xuhui, China
LongRiver Investments is a VC fund in Xuhui focused on Health Care and Medical. LRI Jiangyuan Investment continues to focus on the medical and technology fields.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries LongRiver Investments invests in
Stages LongRiver Investments invests in
Countries LongRiver Investments invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 6 (27%)
- Medical 5 (23%)
- Biotechnology 4 (18%)
- Information Technology 4 (18%)
- Internet 2 (9%)
Stage
- Series B 7 (32%)
- Seed 6 (27%)
- Series A 4 (18%)
- Angel 2 (9%)
- Series D 1 (5%)
Country
- China 10 (45%)
- United States 6 (27%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jiang Zhang
CEO
|
CEO | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OpenJobs AI
|
OpenJobs AI is a AI-Powered Intelligent Hiring Solutions. | Seed / Mar 12, 2026 | |
Flowith
|
Flowith provides an AI workspace that combines knowledge and tools to support writing, content creation, and productivity tasks. | Seed / Mar 04, 2026 | |
|
Spurious
|
Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies. | $35M / Seed / Jan 30, 2026 | |
Worg Pharmaceuticals
|
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases. | $42.6M / Series D / Dec 22, 2025 | |
Oukejian
|
Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases. | $30M / Series B / Dec 16, 2025 | |
Ancher AI
|
A next-generation OS for Content Storytelling in the AI era. | $5M / Seed / Sep 17, 2025 | |
Handing Intelligent
|
Handing Intelligent is a developer and manufacturer of steering systems for passenger cars and commercial vehicles. The company is dedicated to the research and production of various types of steering systems for passenger automobiles and commercial vehicles. Its products include rack and pinion power steering (DP-EPS), cyclic ball power steeringgear (X-EPS), ball screw steering gear (R-EPS), planetary gear steering gear (G-EPS), steering column (C-EPS), and others. | $10M / Series B / Aug 13, 2025 | |
|
Spurious
|
Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies. | $27.8M / Angel / Jun 04, 2025 | |
Rona Therapeutics
|
Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines. | $25M / Series B / Mar 14, 2025 | |
|
Oukejian
|
Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases. | $13.6M / Series A / Jan 13, 2025 | |
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does LongRiver Investments invest in?
LongRiver Investments invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Seed stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact LongRiver Investments?
Public channels for LongRiver Investments include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LongRiver Investments?
The team at LongRiver Investments includes Jiang Zhang (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
